Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Bailey

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Diabetes Care|June 23, 2025
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone TreatmentRalph A DeFronzo, Vivian Fonseca, Vanita R Aroda, et al.
Diabetes Care|April 18, 2025
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 DiabetesJohn B Buse, Steven E Kahn, Vanita R Aroda, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2016
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffoldYuping Zhu, Reynalda K de Jesus, Haifeng Tang, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical EvaluationShawn P Walsh, Aurash Shahripour, Haifeng Tang, et al.
Nature Genetics|April 21, 2009
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line, Harukazu Suzuki, Alistair R R Forrest, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Diabetes Care|June 23, 2025
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone TreatmentRalph A DeFronzo, Vivian Fonseca, Vanita R Aroda, et al.
Diabetes Care|April 18, 2025
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 DiabetesJohn B Buse, Steven E Kahn, Vanita R Aroda, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2016
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffoldYuping Zhu, Reynalda K de Jesus, Haifeng Tang, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical EvaluationShawn P Walsh, Aurash Shahripour, Haifeng Tang, et al.
Nature Genetics|April 21, 2009
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line, Harukazu Suzuki, Alistair R R Forrest, et al.
Pageof 6